+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Healthcare Distribution - Global Market Trajectory & Analytics

  • ID: 5302566
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Attain Med, Inc.
  • Cardinal Health, Inc.
  • Dakota Drug
  • FFF Enterprises, Inc.
  • Henry Schein Inc.
  • McKesson Corporation

Global Healthcare Distribution Market to Reach US$3.2 Trillion by the Year 2027


Amid the COVID-19 crisis, the global market for Healthcare Distribution estimated at US$876.2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Trillion by 2027, growing at a CAGR of 20.2% over the analysis period 2020-2027.Pharmaceutical, one of the segments analyzed in the report, is projected to grow at a 19.9% CAGR to reach US$1.3 Trillion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biopharmaceutical segment is readjusted to a revised 22.4% CAGR for the next 7-year period. This segment currently accounts for a 33.7% share of the global Healthcare Distribution market.

The U.S. Accounts for Over 34.8% of Global Market Size in 2020, While China is Forecast to Grow at a 22.2% CAGR for the Period of 2020-2027


The Healthcare Distribution market in the U.S. is estimated at US$305 Billion in the year 2020. The country currently accounts for a 34.81% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$561.3 Billion in the year 2027 trailing a CAGR of 22.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.1% and 18.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 20.5% CAGR while Rest of European market (as defined in the study) will reach US$561.3 Billion by the year 2027.

Medical Devices Segment Corners a 24% Share in 2020


In the global Medical Devices segment, USA, Canada, Japan, China and Europe will drive the 17.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$169.4 Billion in the year 2020 will reach a projected size of US$510.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$398.3 Billion by the year 2027, while Latin America will expand at a 17.4% CAGR through the analysis period.

Select Competitors (Total 61 Featured) -

  • AmerisourceBergen Corporation
  • Attain Med, Inc.
  • Cardinal Health, Inc.
  • Curascript Specialty Distribution
  • Dakota Drug
  • FFF Enterprises, Inc.
  • Henry Schein Inc.
  • McKesson Corporation
  • Medline Industries
  • Morris & Dickson Co., L.L.C.
  • Mutual Drug
  • Owens & Minor, Inc.
  • Patterson Companies Inc.,
  • Rochester Drug Cooperative, Inc.,
  • Smith Drug Company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Attain Med, Inc.
  • Cardinal Health, Inc.
  • Dakota Drug
  • FFF Enterprises, Inc.
  • Henry Schein Inc.
  • McKesson Corporation
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • The Race Between the Virus & Vaccines Intensifies. Amidst this Chaotic Battle, Where is the World Economy Headed in 2021?
  • EXHIBIT 1: How Fast the World is Vaccinated Will Determine How Soon the Pandemic Will End: Global Number of Annual COVID-19 Vaccine Doses (In Million) for Years 2020 through 2025 by Geographic Region/Country
  • Progress on Vaccinations, Why Should Businesses Care?
  • These are Times When Questions Abound & Answers Are Few
  • With IMF's Upward Revision of Global GDP Forecasts for 2021, Most Companies Are Bullish About a Global Economic Comeback.
  • EXHIBIT 2: A Strong 2021 Economic Rebound Based On Pent-Up Demand Comes as a Relief for Suffering Industries & Markets: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • EXHIBIT 3: Easing Unemployment Levels in 2021 Although Moderate Will Infuse Hope for Industries Reliant on Consumer Discretionary Incomes: Global Number of Unemployed People (In Million) for Years 2017, 2019, 2020, and 2022
  • A Retrospective Review of Year 2020 as the Worst Year in Humanity's History that Left the World in Shambles & Industries and Markets Upended
  • How the Healthcare Industry Has & Continues to be Impacted by the Pandemic & What's the New Normal?
  • The Biggest & Worst Ever Public Health Crisis in Human History Creates a Mixed Bag of Challenges & Opportunities for the Healthcare Industry
  • EXHIBIT 4: With the COVID-19 Pandemic Exposing Global Healthcare Unpreparedness, There is Increasing Policy Led Focus on Rebooting Health Systems Worldwide: Current & Required Healthcare Spending as % of GDP
  • Clinical Diagnostic Laboratories Work Overtime to Manage Giant Waves of COVID Infection Testing Flowing In
  • EXHIBIT 5: Global Clinical Diagnostics Market Reset & Trajectory - Growth Outlook (In %) For Years 2019 Through 2025
  • The Pandemic Triggers Shift in Consumer Behaviour & Engagement With Healthcare Technologies & Services
  • Healthcare Industry Pushed to Adopt Digital Technologies & Innovate to Save Lives Amid the Crisis
  • EXHIBIT 6: Digital Health Technologies Poised to Break New Grounds Post Pandemic: Global Opportunity in Digital Health (In US$ Billion) for Years 2020, 2022, 2024 and 2026
  • How COVID-19 Outbreak Sent the Healthcare Supply Chain Into a Tailspin
  • EXHIBIT 7: Unprecedented Losses Sustained in the Supply Chain Bodes Well for Integration of Emerging Technologies like Blockchain to Enhance Resilience & Reliability: Global Losses in Supply Chain as a % of Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA) in the Year 2020
  • EXHIBIT 8: Far-Flung Supply Chains of the Pharma Industry Cannot be Consolidated Easily & Abruptly, But the Winds of Change Blown by COVID-19 Can Be Felt: Global Number of Plants Registered with the U.S. to Supply Active Pharmaceutical Ingredients as of the Year 2020
  • Healthcare Supply Chain Management Storms Into the Spotlight to Address Disruptions Posed by the Crisis
  • EXHIBIT 9: With Smart Management of Supply Chains Being the Need of the Hour, Healthcare Supply Chain Management to Reach New Highs: Global Opportunity in Healthcare Supply Chain Management (In US$ Million) for Years 2020, 2022, 2024, 2026
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
  • The Importance & Current State Of Drug Distribution Worldwide: A Review
  • Special Focus on India, a Promising Global Pharma Powerhouse
  • Substandard Drugs, an Urgent Challenge in the Supply Chain that Begs to be Addressed
  • Pharmaceutical Thefts & Counterfeiting, A Persistent Challenge in Distribution That Eludes Resolution
  • Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
  • Storming Into the Spotlight Is the Use of Blockchain in Fighting Counterfeiting of Drugs
  • EXHIBIT 10: Rising Incidence of Counterfeiting in the Pharmaceutical Industry Pushes Up the Urgency to Leverage the Security Benefits Promised by Blockchain: Global Number of Pharmaceutical Counterfeiting Incidents for Years 2000, 2005, 2010, 2015, 2019 & 2022
  • Serialization Emerges as an Another Weapon in the Arsenal to Battle Counterfeiting
  • Rising Healthcare Costs Drives Attractiveness of e-Pharmacies
  • EXHIBIT 11: Here's How Healthcare Costs Are Outstripping Global GDP: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
  • Social Distancing Amid the COVID-19 Pandemic Accelerates the Viability & Indispensability of e-Pharmacies, Fast Forwarding Growth by Over 2 Years
  • EXHIBIT 12: Global ePharmacy Sales Breakdown (In %) by OTC Drugs & RX Drugs As of the Year 2021
  • Aging Population, Rising Prevalence of Chronic Diseases & Ensuing Demand for Drugs & Medical Equipment Rank as Major Drivers of Growth in the Market
  • EXHIBIT 13: Aging Population Steps-Up the Burden On Healthcare Systems Including Distribution: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • EXHIBIT 14: Rising Prevalence of Chronic Diseases Amplifies Demand for Pharmaceutical Drugs & Distribution: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
  • Robust Demand for Pharmaceutical Drugs Drives Growth in the Market
  • Pharmaceutical Contract Manufacturing, a Barometer of the Growing Demand & Production of Drugs
  • EXHIBIT 15: More Drugs Being Manufactured Means More Drugs in Distribution: Global Opportunity for Pharmaceutical Contract Manufacturing (In US$ Billion) for Years 2020, 2022, 2024, and 2026
  • Artificial Intelligence to Revolutionize Pharmaceutical Retailing
  • As the World Ramps Up Production of COVID-19 Vaccines, Distribution Emerges Into the Spotlight
  • As Mass Vaccination Drives Kick-in, Challenges in Covid-19 Vaccine Distribution Begin to Surface
  • A Review of Vaccine Distribution Approach in the US
4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

UNITED STATES

CANADA

JAPAN

CHINA

EUROPE

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION
  • Total Companies Profiled: 61

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AmerisourceBergen Corporation
  • Attain Med, Inc.
  • Cardinal Health, Inc.
  • Curascript Specialty Distribution
  • Dakota Drug
  • FFF Enterprises, Inc.
  • Henry Schein Inc.
  • McKesson Corporation
  • Medline Industries
  • Morris & Dickson Co., L.L.C.
  • Mutual Drug
  • Owens & Minor, Inc.
  • Patterson Companies Inc.
  • Rochester Drug Cooperative, Inc.
  • Smith Drug Company
Note: Product cover images may vary from those shown
Adroll
adroll